Back

New therapies to lower LDL-C: how to choose?

25 August 2023 (16:42 - 16:54)
Organised by: Logo
Congress Presentation Part of: Targeting the spectrum of atherogenic lipoproteins: what to do and how to do it Risk Factors and Prevention ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Professor Lale Tokgozoglu

Hacettepe University, Ankara (Turkiye)

4 More presentations in this session

Presentation thumbnail
What are the unmet needs for lipid-lowering in the population?
Professor M. Banach (Lodz, PL)
Slides Video
Presentation thumbnail
Are triglycerides and triglyceride-rich lipoproteins still relevant?
Professor E. Stroes (Amsterdam, NL)
Slides Video
Presentation thumbnail
Why measure Lp(a) and what to do about it?
Professor F. Kronenberg (Innsbruck, AT)
Slides Video
Presentation thumbnail
Targeting the spectrum of atherogenic lipoproteins: what to do and how to do it - discussion
Video

Access the full session

Session thumbnail
Targeting the spectrum of atherogenic lipoproteins: what to do and how to do it
Video

The Event

Event poster

ESC Congress 2023

25 August 2023 16:42 CET
You may be interested in
thumbnail
Congress Presentation
What’s new in LDL lowering?
thumbnail
Congress Session
The LDL-c challenge in patients with high cardiovascular risk: integrating innovative therapies in clinical management
thumbnail
Congress Session
Strategies to reach LDL-C goals in patients with high or very high CV risk: what's new for inclisiran?